1. (a) Fleming A 1929 On the antibacterial action of cultures of a penicillium, with special reference to their use in isolation of B. influenzea Brit. J. Exp. Pathol. 10 226
2. (b) Kahan J S, Kahan F M, Goegelman R, Currie S A, Jackson M, Stapley E O, Miller T W, Miller A K, Hendlin D, Mochales S, Hernandez S, Woodruff H B and Birnbaum J 1979 Thienamycin, a new β-lactam antibiotic I. Discovery, taxonomy, isolation and physical properties J. Antibiot. 32 1
3. (c) Imada A, Kitano K, Kintaka K, Muroi M and Asai M 1981 Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin Nature 289 590
4. (a) Tsuji N, Nagashima K, Kobayashi M, Terui Y, Matsumoto K and Kondo E 1982 The structure of pluracidomycins, a new carbapenem antibiotics J. Antibiot. 35 536; (b) P C Cherry, C E Newall and M Gorman (Eds.) 1980 Chemistry and Biology of β-Lactam Antibiotics (New York: Academic Press); (c) Sykes R B, Cimarusti C M, Bonner D P, Floyd D M, Georgopapadakaou N H, Koster W H, Liu W C, Bush K H, Trejo W H and Wells J S 1981 Monocyclic β-lactam antibiotics produced by bacteria Nature 291 48; (d) Alcaide B and Almendros P 2004 β-lactam as versatile synthetic intermediates for the preparation of heterocycles of biological interest Curr. Med. Chem. 11 1921; (e) Kahan J S, Kahan F M, Goegelman, R, Stapley E O and Hernandez S 1977 Thienamycin Production US Patent 3950357
5. (a) Kou Q, Wang T, Zou F, Zhang S and Chen Q 2018 Design, synthesis and biological evaluation of C(4) substituted monobactums as antibacterial agents against multidrug-resistant gram negative bacteria Eur. J. Med. Chem. 151 98